Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study

Javier Cortés, Chris Twelves, Seth Seegobin et al.|The Lancet|2011

Cited by 1.1k